-
Indazole and Indole Glucagon Receptor Antagonists
2026-09-25
This 2015 study developed indazole- and indole-based glucagon receptor antagonists from an MK-0893-inspired design, then explored structural variation and evaluated selected compounds in vitro and in mice. Compound 16d showed oral activity in acute glucagon-challenge and hGCGR ob/ob mouse models, providing preclinical evidence for the series without establishing clinical efficacy.
-
Diethylmaleate for Redox and GST Assays
2026-09-24
Diethylmaleate offers a practical way to challenge glutathione buffering and test how redox defenses influence chemical stress responses. In a thrips resistance study, inhibiting GST with diethyl maleate sharply weakened antioxidant capacity and increased lambda-cyhalothrin sensitivity—an instructive model for designing controlled, mechanism-aware assays.
-
Hexamethonium Bromide as an Autonomic Probe
2026-09-24
Hexamethonium Bromide can help researchers test how autonomic ganglia contribute to cardiovascular outcomes, beyond simply measuring blood pressure. This article connects ganglionic blockade to a sex-aware angiotensin II mouse study and explains what the experiment can—and cannot—show.
-
Vitamin C Workflows for Organoid and Cancer Research
2026-09-23
Build reproducible Vitamin C assays across tumor-cell and organoid systems with fresh-solution handling, concentration benchmarking, and redox-aware controls. This guide distinguishes established anticancer evidence from an exploratory antiviral application in multilineage HEV organoids.
-
Hepatic sEH–Nrf2 Axis in Osteoporosis
2026-09-22
A 2025 study identifies hepatic soluble epoxide hydrolase as an upstream regulator of osteoclastogenesis through circulating 14,15-EET, 14,15-DHET, inflammatory cytokines, and Nrf2-ARE signaling. By integrating patient samples, ovariectomy-induced osteoporosis, liver-specific knockdown, pharmacological inhibition, and transcriptomics, the work proposes a liver–bone axis relevant to osteoporosis and redox biology.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-22
Grafton et al. developed a high-content phenotypic screening strategy that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to identify cardiotoxic patterns. The approach detected liabilities across mechanistically diverse compound classes and offers a scalable early-stage framework for target discovery and lead optimization.
-
Gamma-Linolenic Acid: A Smarter Assay Framework
2026-09-21
Gamma-linolenic acid (GLA) can support more rigorous anti-inflammatory research when receptor, cell-fate, and translational endpoints are separated. This article develops an assay-design framework linking GLA biology with lessons from antimicrobial surveillance research without overstating clinical or antibacterial implications.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-09-21
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides a fluorescent secondary-antibody route for detecting rabbit IgG in immunofluorescence, immunocytochemistry, immunohistochemistry, flow cytometry, and fluorescence microscopy. It should not be treated as a universal secondary antibody, and its sodium azide-containing formulation requires compatibility assessment before live-cell use.
-
Seeing the Full mRNA Delivery–Translation Equation
2026-09-20
Translational mRNA research increasingly requires two answers at once: where the RNA goes and whether it produces functional protein. This thought-leadership article examines how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) links delivery, intracellular tracking, translation, and LNP design decisions in a single experimental framework.
-
Olaparib (AZD2281): PARP Inhibitor Guide
2026-09-19
Olaparib, also known as AZD2281, is a selective PARP-1/2 inhibitor used to study homologous recombination deficiency and BRCA-associated cancer targeted therapy. Evidence supports activity in selected BAP1-mutated mesothelioma models, while product data support DNA damage response assays and tumor radiosensitization studies.
-
Perphenazine in Reliable Cell Assays
2026-09-19
This scenario-driven guide shows how Perphenazine (SKU B6157) can support reproducible viability, mitochondrial injury, and mechanistic cytotoxicity workflows. It covers solvent handling, exposure design, interpretation, and practical supplier-selection criteria for biomedical research laboratories.
-
Perphenazine and Host-Directed Antibacterial Research
2026-09-18
Perphenazine is more than a dopamine D2 receptor antagonist: its multi-receptor pharmacology, mitochondrial effects, and emerging host-directed antibacterial activity create a valuable translational research framework. This article connects neuropharmacology, macrophage biology, assay design, and repurposing strategy while distinguishing evidence-supported opportunity from unresolved risk.
-
L-Threonine as a Variable in ALP Translation
2026-09-18
A translational framework for using L-Threonine to control metabolic context, improve ALP assay interpretation, and connect cell culture optimization with metal-free nanozyme detection.
-
HotStart 2X Green qPCR Master Mix for Gene Validation
2026-09-17
HotStart 2X Green qPCR Master Mix streamlines SYBR Green assays for gene-expression confirmation, RNA-seq validation, and targeted nucleic acid quantification. Its antibody-mediated hot-start chemistry helps improve specificity while practical controls, melt-curve analysis, and optimized handling protect data quality.
-
Dehydroabietic Acid: Designing Better Metabolic Assays
2026-09-17
Dehydroabietic acid is a dual PPAR-α/γ agonist with applications that depend on rigorous assay design. This guide connects receptor pharmacology with metabolic compartment analysis, using recent triacetin findings to improve interpretation of lipid and insulin-related experiments.